Answers are grounded in this paper and cite their sources.
Fermented rice bran (FRB) attenuates experimental colitis, but its effects on gut microbiome remodeling before disease onset and whether these changes contribute to protection against colitis remain unclear. Furthermore, the contribution of tryptamine (TRY), a fermentation-associated metabolite, to these effects has not been established. We compared FRB, TRY, and their combination (FT) before and after dextran sulfate sodium (DSS)-induced colitis. Female C57BL/6N mice (n = 8/group) received control, FRB (10%), TRY (0.1%), or FT diets for 1 week before DSS administration. Fecal and cecal microbiota were analyzed by 16S rRNA gene amplicon sequencing (n = 6/group), alongside clinical, histopathological, host-response assessments. Before DSS exposure, FRB and FT significantly altered microbial community structure (PERMANOVA, p = 0.004), whereas TRY induced modest changes. FRB enriched Duncaniella, Prevotella, and Alistipes_A_871400; FT enriched Nanosynococcus, UMGS1994, and UBA3263. Following DSS exposure, FRB-containing diets attenuated dysbiosis and showed higher proportions of shared PICRUSt2-predicted pathways between pre-colitis fecal and post-colitis cecal microbiota (FRB, 93.5%; FT, 94.4%) compared with control diet with DSS (88.1%), whereas TRY showed 90.4% continuity. Overall, FRB preconditioned the gut microbiota before inflammatory challenge and promoted microbial resilience, whereas TRY attenuated intestinal injury without comparable microbiome remodeling, suggesting distinct mechanisms underlying their effects.
No takes yet. Share an insight, caveat, or question.
Tasdika et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: